After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Protagonist Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Protagonist Therapeutics Inc is $3.45B. A total of 1.12 million shares were traded on the day, compared to an average of 1.19M shares.
In the most recent transaction, ARTURO MOLINA bought 10,000 shares of PTGX for 55.51 per share on Jun 09 ’25. In a previous transaction on Apr 22 ’25, Ali Asif sold 1,756 shares at 46.00 per share. PTGX shares that Chief Financial Officer owns now total 61,065.
Among the insiders who sold shares, Waddill William D. disposed of 4,000 shares on Mar 17 ’25 at a per-share price of $54.25. This resulted in the Director holding 13,130 shares of PTGX after the transaction. In another insider transaction, WILLIAM D WADDILL bought 4,000 shares at $54.78 per share on Mar 17 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PTGX has a high of $60.60 and a low of $30.67.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PTGX’s latest balance sheet shows that the firm has $326.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.86M in debt and $44.02M in liabilities at the time. Its Book Value Per Share was $11.13, while its Total Shareholder’s Equity was $300.02M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTGX is Buy with a score of 4.80.
